These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 137160)

  • 41. Subcellular mouse alloantigens: cytotoxic immune responses and specific blocking in vitro.
    Wagner H; Boyle W
    Nat New Biol; 1972 Nov; 240(98):92-4. PubMed ID: 4539049
    [No Abstract]   [Full Text] [Related]  

  • 42. Suppression of cytotoxic lymphocyte responses in vitro by soluble products of alloantigen-activated spleen cells.
    Truitt GA; Rich RR; Rich SS
    J Immunol; 1978 Sep; 121(3):1045-51. PubMed ID: 151115
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell-free media of mixed lymphocyte cultures augmenting sensitization in vitro of mouse T lymphocytes against allogeneic fibroblasts.
    Altman A; Cohen IR
    Eur J Immunol; 1976 Jul; 5(7):437-44. PubMed ID: 135686
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effects of adult thymectomy on the growth of 203-glioma in mice--analysis of T cell subpopulation in tumor immunology].
    Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
    No To Shinkei; 1982 Nov; 34(11):1067-75. PubMed ID: 6984337
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Generation of cytotoxic T lymphocytes in vitro. VI. Effect of cell density on response in mixed leukocyte cultures.
    Fitch FW; Engers HD; MacDonald HR; Cerottini JC; Brunner KT
    J Immunol; 1975 Dec; 115(6):1688-94. PubMed ID: 127012
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of T, B and adherent cells in the in vitro immune response of TEPC-183-bearing mice.
    Patel M; Havas HF
    Immunology; 1982 May; 46(1):97-105. PubMed ID: 6978846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulation of cellular anti-tumour responses by tumour-specific T suppressor lymphocytes.
    Haubeck HD; Stutenkemper R; Kölsch E
    Clin Exp Immunol; 1988 Oct; 74(1):47-52. PubMed ID: 2975538
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of the immune response by subclasses of T lymphocytes. I. Interactions between pre-killer T cells and regulatory T cells obtained from peripheral lymphoid tissues of mice.
    Cantor H; Simpson E
    Eur J Immunol; 1975 May; 5(5):330-6. PubMed ID: 1086234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulatory mechanisms in cell-mediated immune responses. II. Comparison of culture-induced and alloantigen-induced suppressor cells in MLR and CML.
    Nadler LM; Hodes RJ
    J Immunol; 1977 May; 118(5):1886-95. PubMed ID: 140197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Augmentation of humoral and cell mediated immune responses by Thujone.
    Siveen KS; Kuttan G
    Int Immunopharmacol; 2011 Dec; 11(12):1967-75. PubMed ID: 21884824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stimulation of lymphoid cells from normal and immune mice by syngeneic BALB/c plasma cell tumors.
    Boyer PJ; Fahey JL
    J Immunol; 1976 Jan; 116(1):202-9. PubMed ID: 128571
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on the induction and expression of T cell-mediated immunity. 3. Amplification by papain of the generation of cytotoxic lymphocytes to allogeneic cells.
    Kedar E; Bonavida B
    J Immunol; 1974 Oct; 113(4):1386-9. PubMed ID: 4153487
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of Aerva lanata on cell-mediated immune responses and cytotoxic T-lymphocyte generation in normal and tumor-bearing mice.
    Siveen KS; Kuttan G
    J Immunotoxicol; 2012; 9(1):25-33. PubMed ID: 22129065
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Active suppression of host-vs-graft reaction in pregnant mice. VI. Soluble suppressor activity obtained from decidua of allopregnant mice blocks the response to IL 2.
    Clark DA; Chaput A; Walker C; Rosenthal KL
    J Immunol; 1985 Mar; 134(3):1659-64. PubMed ID: 3871455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Stimulation and suppression of cellular immunity in mice during liver regeneration].
    Rakhmilevich AL; Sidorenko ON
    Biull Eksp Biol Med; 1986 May; 101(5):591-4. PubMed ID: 2939891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
    Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced TNP-reactive helper T cell activity and its utilization in the induction of amplified tumor immunity that results in tumor regression.
    Fujiwara H; Moriyama Y; Suda T; Tsuchida T; Shearer GM; Hamaoka T
    J Immunol; 1984 Mar; 132(3):1571-7. PubMed ID: 6198397
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factor(s) from Ehrlich Ascites cells responsible for delayed rejection of skin allografts in mice and its assay on lymphocytes in vitro.
    Gresser I; Vignaux F; Maury C; Lindahl P
    Proc Soc Exp Biol Med; 1975 May; 149(1):83-8. PubMed ID: 1096161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Specific priming of mouse thymus-dependent lymphocytes to allogeneic cells in vitro.
    Andersson LC; Häyry P
    Eur J Immunol; 1973 Sep; 3(9):595-9. PubMed ID: 4271927
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effects of humoral factors of the mastocytoma P815 cells on the formation of allospecific killers in mixed culture of lymphocytes and their cytotoxic activity].
    Medvedev AE; Dostman U; Flegel' A
    Biull Eksp Biol Med; 1989 Aug; 108(8):224-6. PubMed ID: 2529921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.